Header Logo

Connection

BENJAMIN FRANKFORT to Erlotinib Hydrochloride

Back to Details
This is a "connection" page, showing publications BENJAMIN FRANKFORT has written about Erlotinib Hydrochloride.
BENJAMIN FRANKFORT
Connection Strength
0.067
Erlotinib Hydrochloride
  1. Periocular cutaneous toxicity and cicatricial ectropion: a potential class effect of antineoplastic agents that inhibit EGFR signaling. Ophthalmic Plast Reconstr Surg. 2007 Nov-Dec; 23(6):496-7.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.